Biomarkers of lipid peroxidation, airway inflammation and asthma

European Respiratory Journal

Volumn 21, Issue 1, 2003, Pages 177-186

  Wood, L G ^a   Gibson, P G ^a   Garg, M L ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Antioxidants; Asthma; Isoprostanes; Lipid peroxidation; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; CAROTENOID; CATALASE; ETHANE; FLAVONOID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROCARBON; ISOPROSTANE DERIVATIVE; LIPID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PENTANE; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROLOX C; ZINC;

AIRWAY; ASTHMA; BREATH ANALYSIS; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATORY CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELIABILITY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SPUTUM ANALYSIS;

EID: 0037252642     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00017003a     Document Type: Review

References (101)

1. Barnes PJ. Reactive oxygen species and airway inflammation. Free Rad Biol Med 1990; 9: 235-243.
2. Downs SH, Marks GB, Sporik R, Belosouva EG, Car NG, Peat JK. Continued increase in the prevalence of asthma and atopy. Arch Dis Child 2001; 84: 20-23.
3. Fogarty A, Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000; 30: 615-627.
4. Doelman CJA, Bast A. Oxygen radicals in lung pathology. Free Rad Biol Med 1990; 9: 381-400.
5. Levine SJ. Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 1995; 43: 241-249.
6. Neyens HJ, Raatgeep RE, Degenhart HJ, Duiverman EJ, Kerrebijn KF. Altered leukocyte response in relation to the basic abnormality in children with asthma and bronchial hyperresponsiveness. Am Rev Respir Dis 1984; 130: 744-747.
7. Cluzel M, Damon M, Chanez P, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 1987; 80: 195-201.
8. Jarjour NN, Calhoun WJ. Enhanced production of oxygen radicals in asthma. J Lab Clin Med 1994; 123: 131-136.
9. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
10. Radi R, Beckman J, Bush K, Freeman B. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487.
11. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999; 274: 25933-25944.
12. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273-1276.
13. Rhoden KJ, Barnes PJ. Effect of hydrogen peroxide on guinea-pig tracheal muscle in vitro: role of cyclooxygenase and airway epithelium. Br J Pharmacol 1989; 98: 325-330.
14. Katsumata U, Miura M, Ichinose M, et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990; 141: 1158-1161.
15. Weiss EB, Bellino JR. Leukotriene-associated toxic oxygen metabolites induces airway hyperreactivity. Chest 1986; 89: 709-716.
16. Adler KB, Holden-Stauffer WJ, Repine JE. Oxygen metabolites stimulate release of high-molecular weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via arachidonic acid dependent mechanism. J Clin Invest. 1990; 85: 75-85.
17. Phipps RJ, Denas SM, Sielczak MV, Wanner A. The effect of 0.5ppm ozone on glycoprotein secretion, ion and water fluxes in sheep trachea. J Appl Physiol 1986; 60: 918-927.
18. Doelman CJA, Leurs R, Oosterom WC, Bast A. Mineral dust exposure and free radical-mediated lung damage. Exp Lung Res 1990; 16: 41-55.
19. del Maestro RF, Bjork J, Arfors K. Increase in microvascular permeability induced by enzymatically generated free radicals. I. In vivo study. Microvasc Res 1981; 22: 239-254.
20. Tate RM, van Benthuysen KM, Shasby DM, McMurtry IF, Repine JE. Oxygen-radical-mediated permability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis 1982; 126: 802-806.
21. Biagioli MC, Kaul P, Singh I, Turner RB. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Rad Biol Med 1999; 26: 454-462.
22. Kawikova I, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, Belvisi MG. 8-epi-PGF2alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 1996; 153: 590-596.
23. Fukunaga M, Takahashi K, Badr KF. Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane. Biochem Biophys Res Comm 1993; 195: 507-515.
24. Held HD, Uhlig S. Mechanisms of endotoxin-induced airway and pulmonary vascular hypperreactivity in mice. Am J Respir Crit Care Med 2000; 162: 1547-1552.
25. Okazawa A, Kawikova I, Cui Z, Skoogh B, Lotvall J. 8-epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 1997; 155: 436-441.
26. Kromer BM, Tippins JR. Coronary artery constriction by the isoprostane 8-epi-prostaglandin F2alpha. Br J Pharmacol 1996; 119: 1276-1280.
27. Mobert J, Becker BF, Zahler S, Gerlach E. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 1997; 29: 789-794.
28. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35: 967-974.
29. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensation in asthma patients. Am J Respir Crit Care Med 1999; 160: 216-220.
30. Dworski R, Murray JJ, Roberts LJI, et al. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Am J Respir Crit Care Med 1999; 160: 1947-1951.
31. Takahashi K, Nammour TM, Fukunaga M, Ebert JD, Morrow JD, Roberts U. Glomerular actions of a free radical generated novel prostaglandin, 8-epi-PGF2α, in the rat. Evidence for interactions with thromboxane A2 receptors. J Clin Invest 1992; 90: 136-141.
32. Fukunaga M, Yura T, Grygorczyk R, Badr KF. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. Am J Physiol 1997; 272: F477-F483.
33. Quaggiotto P, Garg ML. Isoprostanes: indicators of oxidative stress in vivo and their biological activity. In: Basu TK, Norman T, Garg ML, eds. Antioxidants in Human Health and Diseases. Oxford, CAB International, 1999; pp. 393-410.
34. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 1996; 154: 1055-1060.
35. Kalayci O, Besler T, Kilinc K, Sekerel BE, Saraclar Y. Serum levels of antioxidant vitamins (alpha tocopherol, beta carotene, and ascorbic acid) in children with bronchial asthma. Turkish J Pediatr 2000; 42: 17-21.
36. Shanmugasundaram KR, Kumar SS, Rajajee S. Excessive free radical generation in the blood of children suffering from asthma. Clinica Chimica Acta 2001; 305: 107-114.
37. Ozarus R, Tahan V, Turkmen S, et al. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 2000; 5: 289-292.
38. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10: 1235-1241.
39. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000; 162: 1450-1454.
40. Olopade CO, Zakkar M, Swedler WI, Rubinstein I. Exhaled pentane levels in acute asthma. Chest 1997; 111: 862-865.
41. Aderele WI, Ette SI, Oduwole O, Ikpeme SJ. Plasma vitamin C (ascorbic acid) levels in asthmatic children. Afr J Med Sci 1985; 14: 115-120.
42. Vural H, Uzun K. Serum and red blood cell antioxidant status in patients with bronchial asthma. Can Respir J 2000; 7: 476-480.
43. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482-483.
44. Mohan IK, Das UN. Oxidant stress, antioxidants, nitric oxide and essential fatty acids in bronchial asthma. Med Sci Res 1997; 25: 307-309.
45. Smith LJ, Houston M, Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 1993; 147: 1461-1464.
46. Kurosawa M, Kobayashi H, Nakano M. Cu-Zn superoxide dismutase activities in platelets from stable bronchial asthmatic patients. Int Arch Allergy Immunol 1993; 101: 61-65.
47. DeRaeve HR, Thunnissen FBMJ, Kaneko FT, et al. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: Correction by inhaled corticosteroid in vivo. Am J Physiol 1997; 272: L148-L154.
48. Smith LJ, Shamsuddin M, Sporn PHS, Denenberg M, Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Rad Biol Med 1997; 22: 1301-1307.
49. Fenech AG, Ellul-Micallef R. Selenium, glutathione peroxidase and superoxide dismutase in Maltese asthmatic patients: effect of glucocorticoid administration. Pulm Pharmacol Ther 1998; 11: 301-308.
50. Comhair SAA, Bhathena PR, Dweik RA, Kavuru M, Erzurum SC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000; 355: 624.
51. Tekin D, Ayse Sin B, Mungan D, Misirligil Z, Yavuzer S. The antioxidant defense in asthma. J Asthma 2000; 37: 59-63.
52. Novak Z, Nemeth I, Gyurkovits K, Varga SI, Matkovics B. Examination of the role of oxygen free radicals in bronchial asthma in childhood. Clinica Chimica Acta 1991; 201: 247-252.
53. Powell CVE, Nash AA, Powers HJ, Primhak RA. Antioxidant status in asthma. Pediatr Pulmonol 1994; 18: 34-38.
54. Vural H, Uzun K, Uz E, Kocyigit A, Cigli A, Akyol O. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. J Trace Elements Med Biol 2000; 14: 88-91.
55. Goldey DH, Mansmann HC, Rasmussen AI. Zinc status of asthmatic, prednisone-treated asthmatic, and non-asthmatic children. J Am Dietetic Assoc 1984; 84: 157-163.
56. Bibi H, Schlesinger M, Tabachnik E, Schwartz Y, Iscovitz H, Iaina A. Erythrocyte glutathione peroxidase activity in asthmatic children. Ann Allergy 1988; 61: 339-340.
57. Flatt A, Pearce N, Thomson CD, Sears M, Robinson MF, Beasley R. Reduced selenium in asthmatic subjects in New Zealand. Thorax 1990; 45: 95-99.
58. Hasselmark L, Malmgren R, Unge G, Zetterstrom O. Lowered platelet glutathione peroxidase activity in patients with intrinsic asthma. Allergy 1990; 45: 523-527.
59. Pearson DJ, Suarez-Mendez VJ, Day JP, Miller PF. Selenium status in relation to reduced glutathione peroxidase activity in aspirin-sensitive asthma. Clin Exp Allergy 1991; 21: 203-208.
60. Misso NLA, Powers KA, Gillon RL, Stewart GA, Thompson PJ. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy 1996; 26: 838-847.
61. Kadrabova J, Madaric A, Kovakicova Z, Podivinsky F, Ginter E, Gazdik F. Selenium status is decreased in patients with intrinsic asthma. Biol Trace Element Res 1996; 52: 241-248.
62. Stone J, Hinks LJ, Beasley R, Holgate ST, Clayton BA. Reduced selenium status of patients with asthma. Clin Sci 1989; 77: 495-500.
63. Dauletbaev N, Rickmann J, Viel K, Buhl R, Wagner T-O-F, Bargon J. Glutathione in induced sputum of healthy individuals and patients with asthma. Thorax 2001; 56: 13-18.
64. Toth KM, Berger EM, Beehler CJ, Repine JE. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide than do erythrocytes from nonsmokers. Am Rev Respir Dis 1986; 134: 281-284.
65. Borm PJ, Bast A, Wouters EF, Slangen JJ, Swaen GM, Border DE. Red blood cell antioxidant parameters in healthy elderly control subjects versus silicosis patients. Free Rad Res Comm 1987; 3: 117-127.
66. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998; 53: 668-672.
67. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
68. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001; 20: Suppl, 2, 157-165.
69. Montuschi P, Paredi P, Corradi M. 8-isoprostane, a biomarker of oxidative stress is increased in cystic fibrosis. Am J Respir Crit Care Med 1999; 159: A271.
70. Montuschi P, Ciabattoni G, Paredi P, et al. 8-isoprostane as a biomarker of oxidative stress in inter-stitial lung diseases. Am J Respir Crit Care Med 1998; 158: 1524-1527.
71. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162: 1175-1177.
72. Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2a III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158: 1709-1714.
73. Awad JA, Roberts LJ 2nd, Burk RF, Morrow JD. Isoprostanes-prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage. Gastroenterol Clin N Am 1996; 25: 409-427.
74. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-9387.
75. Awad JA, Morrow JD. Excretion of F2-isoprostanes in bile: A novel index of hepatic lipid peroxidation. Hepatology 1995; 22: 962-968.
76. Awad JA, Horn J-L, Roberts LJ, Franks JJ. Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F2-isoprotanes. Anesthesiology 1996; 84: 910-916.
77. Morrow JD, Roberts LJ 2nd. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996; 51: 1-9.
78. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198-1203.
79. Collins CE, Quaggiotto P, Wood L, O'Loughlin EV, Henry RL, Garg ML. Elevated plasma levels of F2alpha isoprostane in cystic fibrosis. Lipids 1999; 34: 551-556.
80. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentration following respiratory exacerbations in cystic fibrosis is associated with elevated oxidative stress. Am J Clin Nutr 2002; 75: 668-675.
81. Roberts LJ 2nd, Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1997; 1345: 121-135.
82. Gopaul NK, Zacharowski K, Halliwell B, Anggard EE. Evaluation of the postprandial effects of a fast-food meal on human plasma F2-isoprostane levels. Free Rad Biol Med 2000; 28: 806-814.
83. Richelle M, Turini ME, Guidoux R, Tavazzi I, Mefairon S, Fay LB. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Letters 1999; 459: 259-262.
84. Klein T, Reutter F, Schweer H, Nusing RM. Generation of the isoprostane 8-epi-prostaglandin F2 alpha in vitro and in vivo via the cyclooxygenases. J Pharmacol Exp Ther 1997; 282: 1658-1665.
85. Pratico D, Fitzgerald GA. Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem 1996; 271: 8919-8924.
86. Pratico D, Lawson JA, Fitzgerald GA. Cyclooxygenase dependent formation of the isoprostane, 8-epi prostaglandin F2alpha. J Biol Chem 1995; 270: 9800-9808.
87. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. FEBS Letters 1987; 213: 9-14.
88. Pincemail J, Defraigne JO, Limet R. Oxidative stress in clinical situations - fact or fiction? Eur J Anaesthesiol 1996; 13: 219-234.
89. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-493.
90. Tatum VL, Changchit C, Chow CK. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids 1990; 25: 226-229.
91. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. TIBS 1990; 15: 129-135.
92. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm 1989; 6: 67-75.
93. Tatzber F, Wonisch W, Schmidt E, Esterbauer H. Quantitative determination oLAb titers in various animal species. Biofactors 1997; 6: 125-130.
94. Holvoet P. Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiologica 1998; 53: 253-260.
95. Cross CE, van der Vliet A, O'Neill C, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect 1994; 102: Suppl. 10, 185-191.
96. Wayner DDM, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Letters 1985; 187: 33-37.
97. Langley SC, Brown RK, Kelly FJ. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993; 33: 247-250.
98. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16: 1008-1015.
99. Horvarth I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998; 158: 1042-1046.
100. Anah CO. High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 1980; 32: 132-137.
101. Hasselmark L, Malmgren R, Zetterstrom O, Unge G. Selenium supplementation in intrinsic asthma. Allergy 1993; 48: 30-36.